Vital Protein in Healthy Fertilization Process Identified
News Jul 27, 2015
The protein RGS2 can delay an egg’s development into an embryo in order to allow time for sperm to arrive and merge with the egg in a healthy fertilization process. The embryo cannot survive without the male chromosomes.
“These findings show the critical role that the protein RGS2 plays in preserving the fertilizability of the ovulated egg,” said Carmen Williams, M.D., Ph.D., lead researcher at the National Institute of Environmental Health Sciences, part of the NIH. “Other researchers have shown that RGS2 plays an important role in regulating heart function and blood pressure, but this is the first demonstration of the protein’s significant role in fertilization.”
Dr. Williams explained that the immature egg found in the ovary is not very good at rallying the necessary calcium signaling that is needed to respond to sperm. However, during the maturation process, the egg stores calcium, preparing it for fertilization. At fertilization, the sperm causes calcium to release within the egg, turning it into a developing embryo.
The mouse study shows that during maturation the egg synthesizes RGS2, which suppresses calcium signaling. This safety mechanism ensures that the egg does not begin releasing calcium and start developing before the sperm arrives. Beginning development too early prevents the egg from merging with the sperm.
The RGS2 protein is being looked at as a therapeutic target for hypertension and other heart ailments. “Understanding the role RGS2 plays in reproduction is important when considering the possible benefits and side effects of any new treatments, as well as understanding the impact that toxins might have on human fertility,” said Linda Birnbaum, Ph.D., director of NIEHS and the National Toxicology Program.
Cell Chimeras Provide Muscular Dystrophy BreakthroughNews
Fusing together healthy cells with those affected by Duchenne Muscular Dystrophy could improve muscle function.READ MORE
Biomarkers to Personalize Treatment of Head and Neck CancerNews
Researchers at A.C. Camargo Cancer Center in Brazil have found markers in the blood of head and neck cancer patients that can help identify cases that are likely to evolve to metastasis or develop local relapse after treatment.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018